PRESS-RELEASE ·Filed Apr 22, 2026
Press release · Earnings
Final — all horizons settled through T+60d
ZVRA ▲ +21.73% at T+60d
NEUTRAL call +21.73% · α vs SPY +16.96% · entry $10.49 → $12.77
T+1d
-3.62%
call -3.62% · α -3.23%
$10.11
settled 6mo ago
T+5d
-7.44%
call -7.44% · α -7.49%
$9.71
settled 6mo ago
T+20d
-2.76%
call -2.76% · α -5.93%
$10.20
settled 5mo ago
T+60d
+21.73%
call +21.73% · α +16.96%
$12.77
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Zevra Therapeutics announced it will host a conference call on May 6, 2026 to discuss its Q1 2026 results.
Key Facts
- Zevra Therapeutics announced it will host a conference call on May 6, 2026 to discuss its Q1 2026 results.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3278855 |
4 reports for ZVRA
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 10w ago | Insider Cluster | $11.57 | awaiting T+60 | — | $9.53 (−17.63%) |
May 6, 2026 24w ago | 8-K | $11.00 $10.06 | ▼ −8.59% | ▼ −12.42% | $9.53 (−13.36%) |
Apr 22, 2026 26w ago | Press Release | $10.49 $12.77 | ▲ +21.73% | ▲ +16.96% | $9.53 (−9.15%) |
Mar 2, 2026 34w ago | Press Release | $9.09 $10.32 | ▲ +13.53% | ▲ +4.20% | $9.53 (+4.84%) |
Showing 4 of 4
US Market Status
Market Closed — Opens in 1h 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers